No Data
Health Catalyst: Vitalware Sale Seen as Value-Creating, Enabling Debt Paydown and Strategic Focus; Buy Rating and $2 Price Target Reiterated
Health Catalyst +46% HCAT Definitive Agreement; ADC Therapeutics ADCT -57% Phase 3 Data
12 Health Care Stocks Moving In Thursday's Intraday Session
Analysts Are Bullish on Top Healthcare Stocks: Health Catalyst (HCAT), Medicus Pharma Ltd (MDCX)
Express News | Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield
Health Catalyst Jumps on Announcement to Sell Vitalware to Med‐Metrix for $147M